Workshop 1. Non Cultured Epidermal Cell Suspension Preparation and its modification

Similar documents
6. Metabolic Disorders of Pigmentation 53 Imran Majid Hypopigmentation 53 Hyperpigmentation 55

นพ.วาสนภ วช รมน หน วยโรคผ วหน ง คณะแพทยศาสตร โรงพยาบาลรามาธ บด

Trichloroacetic Acid Peel 15% + NB-UVB Versus Trichloroacetic Acid Peel 25% + NB-UVB for Stable Non-Segmental Vitiligo

2018 FINAL PROGRAM GUIDE November 9-10, 2018 I Detroit, MI, USA

Vitiligo An Indian Perspective

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Maintenance Therapy of Adult Vitiligo with 0.1% Tacrolimus Ointment: A Randomized, Double Blind, Placebo Controlled Study

Session III. Session IV

Vitiligo & Pigmentary Disorders Masterclass. Vitiligo Research Foundation & Israel Society of Dermatology & Venerology. Tel Aviv. November 25-26, 2015

Index. derm.theclinics.com. Note: Page numbers of article titles are in boldface type.

Treatment of segmental vitiligo with normal-hair follicle autograft

Therapeutic management of vitiligo

Department of Dermatology, Postgraduate Institute of Medical Education and Research, Chandigarh, , India. What s already known about this topic?

Correspondence should be addressed to Amir Kalafi;

Clinical Course of Segmental Vitiligo: A Retrospective Study of Eighty-Seven Patients

Saturday, 30 th September 2017 WCCPCI-2017 HALL B

BREAKS NETWORKING EVENTS PARALLEL SESSIONS INDUSTRY SUPPORTED SESSIONS Academy of Autoimmunity SYMPOSIUM

Clinical Study Narrow-Band Ultraviolet B versus Oral Minocycline in Treatment of Unstable Vitiligo: A Prospective Comparative Trial

Prospective Study of Response to NBUVB in Various Forms of Vitiligo in Different Age Groups.

A Vitiligo Update for Pharmacists: Current Practices and Future Advances

Recommendations ABSTRACT

Review Article SURGERIES IN VITILIGO - A REVIEW ARTICLE

Direct Melanocytes Transplant from Normal Donor Area into Vitiliginous Recipient Area by Dermabrasion Technique *

Vitiligo: How many types?

INDUSTRY SUPPORTED SESSIONS. Auditorium I Auditorium II Auditorium VIII Auditorium III Pavilion 3A Pavilion 3B. Academy of Autoimmunity

2018 ABSTRACT BOOK November 9-10, 2018 I Detroit, MI, USA

S C I E N T I F I C P R O G R A M

S.I.S. INTERNATIONAL SCHOOL OF SENOLOGY S.I.S. / I.S.S.

Epidemiological study, clinical spectrum and associations of childhood vitiligo in a tertiary care centre

For personal use only

Making decisions about available treatments

Emirates Dermatology Society

Istanbul Master Class Prof Sibel Alper- President November 2014

Acral lesions of vitiligo: why are they resistant to photochemotherapy?

Roundtable on Vitiligo

B I ABOUT BI DISEASE AREA & MECHANISM OF ACTION. For journalists outside UK/US/Canada only B A C K G R O U N D E R

RETRIEVAL WORKSHOP 4 TH N A T I O N A L (OXFORD COURSE) Date: 4 th & 5 th May Venue: M. S. Ramaiah Advanced Learning Centre, Bangalore

Short Range Outlook for Steel Demand Autumn OECD Steel Committee, Paris, 10 December Short Range Outlook overview

CLINICAL REPORT. Predictive Model for Response Rate to Narrowband Ultraviolet B Phototherapy in Vitiligo: A Retrospective Cohort Study of 579 Patients

CLINICAL REPORT. Predictive Model for Response Rate to Narrowband Ultraviolet B Phototherapy in Vitiligo: A Retrospective Cohort Study of 579 Patients

INDUSTRY SUPPORTED SESSIONS. Auditorium I Auditorium II Auditorium VIII Auditorium III Pavilion 3A Pavilion 3B. Academy of Autoimmunity

Research Collaborations: Lessons from PeDRA and the SPD

Avoiding Litigations. Be sure Be safe! - Dom Daniel Editor EXECUTIVE EDITOR & PUBLISHER

The program is divided into 10 sub-specialty sessions over 2 days, interspersed with posters exhibits, symposia and workshops.

GOLD SPONSORS SILVER SPONSOR BRONZE SPONSORS EXHIBITORS

presents October 2 nd 6 th, 2008 Salishan Resort, Gleneden Beach, Oregon K E Y N O T E S E S S I O N

Original Policy Date

Enriched RWE study in the Nordics a case study

Dr. Venkataram Mysore MD.DNB.DipRCPath (Lond) FRCP (Glasgow)

1 National CME on Transplant Critical Care

Vitiligo. Vasanop Vachiramon, MD. Assistant professor Division of Dermatology, Ramathibodi Hospital

TUESDAY, MARCH 28, 2017 WEDNESDAY, MARCH 29, 2017 WELCOME RECEPTION (VIENNA CITY HALL)

Treatment Recalcitrant Vitiligo with Narrow Band UVB M J B

VENUE. NMI Natural and Medical Sciences Institute at the University of Tübingen. Markwiesenstrasse 55, Reutlingen, Germany

A Study on Effectiveness of Platelet-poor Plasma as a Media in Autologous Noncultured Epidermal Cell Suspension in the Treatment of Stable Vitiligo

LIVE SURGERY AND CME ON BRACHIAL PLEXUS AND PERIPHERAL NERVE INJURIES. JPNATC, AIIMS, New Delhi

rd th 3-4 December 2016, ITC Grand Chola, Chennai, India SCIENTIFIC PROGRAM

28th Annual Conference of Indian Society of Organ Transplantation. 13th-15th Oct, 2017 Brilliant Convention Center, Indore.

Injection Techniques Questionnaire (ITQ) WorldWide Results Needle Gauge

Pathophysiology of melasma. Emel ERDAL ÇALIKOĞLU

( ISNR 2009) PROGRAMME. ( Incorporating Ramachandra Advanced Interventional Neuroradiology (RAIN- 2009)

C.V. Updated on November, 2015

Lions Meeting. Nov. 8th. (17 Lions attending so far!) Kindness Matters October 29, LIONS 2018 CALENDAR Click Here

Summary of papers presented at the VETF Meeting in Honor of Yvon Gauthier, Bordeaux, 1st March 2008

This is a repository copy of Programmed death 1 expressing regulatory T cells in vitiligo.

Accepted Date : 18-Jan-2011 Article type : Original Article. What's already known about this topic?

Preliminary Program Outline

Surgical management of vitiligo

Treatment Seeking Behavior In Patients Suffering From Melasma Aneela Asghar, Tariq Rashid

ERS School Course Programme Lung Transplantation: Sharing Experience Across Europe February 23-25, 2012 Strasbourg, France

ECPC ANNUAL CONGRESS ECPC GENERAL ASSEMBLY

Narrow-band UVB PHOTOTHERAPY for Skin Diseases

Day-1 (3 rd November 2018)

This is a Preliminary Program subject to further changes due to necessary timetable rescheduling.

Background Head Quarter Promoter Holding Pattern Turnover

EyePEP 2018 FINAL PROGRAM. Education meets excellence. October 7-13, 2018 Patodia Auditorium L V Prasad Eye Institute, Hyderabad

Vitiligo is an acquired cutaneous depigmentation

Vitiligo is an acquired cutaneous depigmentation disorder

The Integumentary System: An Overview

ITCC-P4 International Workshop

VITILIGO. Made by: Basma Noor, Maryam Mahjoub, Irin Chankao and Sara Samadi.

Retreat Program Friday, Nov. 15, 2013

Survey Responses to the EUROPEAN COCOA FORUM 2016

Preceptorship at the Yonsei Cancer Center Gastric Cancer Team. Date : July, 2018 Place: Yonsei Cancer Center, Seoul, Korea

Epidermal skin grafting in vitiligo: a pilot study

AMC MET Medical College L.G.Hospital Campus, Maninagar, Ahmedabad. Phone: to , Fax Website:-

CIPM 13 - Day 1. Venue: Dr.DY Patil medical college building, 3rd floor Auditorium, Nerul, New Mumbai

SPR Annual Meeting & Postgraduate Course May 15-19, 2018

VITAMIN D AND THE SKIN JOYCE FARAH MD MS FAAD FARAH DERMATOLOGY AND COSMETICS, LLC ASSISTANT PROFESSOR OF MEDICINE AND ENT UPSTATE MEDICAL UNIVERSITY

Multivariate Analysis of Factors Associated with the Koebner Phenomenon in Vitiligo: An Observational Study of 381 Patients

TUESDAY, MARCH 26, 2019 WEDNESDAY, MARCH 27, 2019

A STUDY OF EFFICACY RESULT BETWEEN TOPICAL HERBAL RHUBARB LIQUID AND LIQUID BASE FOR THE TREATMENT OF MELASMA IN THAI PEOPLE

Towering Further Heights

TUESDAY, MARCH 26, 2019 WEDNESDAY, MARCH 27, 2019

FRIDAY, JANUARY 18, :00 The Nuclear Cardiology Consultation: Pearls and Impact on Outcomes Daniel S. Berman, MD

UltraEMG Course Schedule 2015


Cardiac CT Course Part A November 2014 Mohammed Bin Rashid Academic Medical Center Dubai Healthcare City, Dubai, UAE

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Transcription:

Day 1 Nov 28, Friday Registration: 8am onwards Workshops 9.00 am to 12.30 pm Workshop 1. Non Cultured Epidermal Cell Suspension Preparation and its modification Workshop 2. Hair follicle cell suspension preparation and combination methods Workshop 3 How to set up basic lab for pigment cell research Lunch : 1 pm to 2 pm Inauguration: 2.00 pm to 2.15 pm Session 1: Vitiligo : Basic Science Chairs: Prof T Lotti, Dr R Gokhale 2.20 pm to 2.40 pm Dissecting the functional network across keratinocytes, melanocytes and microbiota of skin in vitiligo Dr Rajesh S. Gokhale 2.40 pm to 3.00 pm Genomic changes in vitiligo: causal effect or the after effect Dr. Vivek Natarajan 3.00 pm to 3.20 pm A candidate gene approach for understanding the complex genetics of vitiligo Dr R Begum 3.20 pm to 3.40 pm Mosaicism in Vitiligo- A new dimension to current concepts. Dr Dr Ratnam Attili 3.40 pm to 4.00 pm Genetic background of vitiligo: Foreground of auto-immunity?

Session 2. Vitiligo : Epidemiology and classification Chairs: Prof BB Mahajan, Prof KJPS Puri 4.00 pm to 4.15 pm Newer Classification of vitiligo Dr Khalid Ezzedine (France) 4.15 pm to 4.30 pm Acral Vitiligo- A distinct pattern Dr S Attili 4.30 pm to 4.45 pm Segmental vitiligo and mosaicism in vitiligo Dr N Sarma Epidemiology and of Beyond consensus Session 3 Vitiligo : Stability issues Chairs: Dr A Valia, Dr G Singh 5.00 pm to 5.15 pm How can we assess the Dr Benzekri Laila (Morroco) Clinical and histological studies 5.15 pm to 5.30 pm Dr Koushik Lahiri what is not 5.30 pm to 5.45pm Is lesional stability more relevant than disease stability for surgical intervention in vitiligo? A multi-centric study? Dr I Majid Session 4: Pigmentation Research Chairs: Prof D Mathur, Prof V Shankar 5.45pm to 6.05 pm Skin Color Evaluation Dr M Verschoore (France) 6.05pm to 6.20 pm Periocular pigmentation Dr M Chatterjee 6.20 pm to 6.35 pm Management of melasma: where is the evidence Dr S Panda 6.35pm to 6.50 pm Pigmentary demarcation lines: where do we stand? Dr S Malakar Dinner: 8 pm onwards

Saturday, 29 th Nov 2014 Session 5 Vitiligo : Clinical aspects Chairs: Prof B Laila, Prof Samia Esmat 8.15 am to 8.30 am Depigmentation therapies in vitiligo Dr D M Thappa 8.30 am to 8.45 am Basic science and translational research that led to the development of bfgf peptide to treat vitiligo Dr A Ramaiah 8.45 am to 9.00 am Topical treatments in vitiligo: An overview Dr V K Sharma 9.00am to 9.20 am Prevention of relapses in vitiligo lesions Dr T Passeron (France) 9.20 am to 9.30 am Targeted UVB phototherapy in vitiligo: comparison study between once weekly and twice weekly treatment regimens Dr I Majid Session 6 Vitiligo : Repigmentation Strategies Chairs: Dr SD Mehta, Prof Tag Anbar 9.30 am to 9.45 am Failure to repigment: why, and what to do Dr Igor Korobko (Russia) 9.45 am to 10.00 am How to improve the marginal repigmentation: Updated review Yvon Gauthier (France) 10.00 am to 10.20 am Alfamelanotide and Phototherapy: Current concepts Dr I Hamzavi (USA) 10.20 am to 10.40 am How to deal with difficult to treat areas? Dr T Passeron (France)

Session 7 : Vitiligo : State of the art Chairs: Dr D Parikh, Prof T Passeron 11.00am to 11.20am Vitiligo: What s New, What s True Prof Torello Lotti (Italy) 11.20.am to 11.40am A pathogenesis- based approach for the treatment of vitiligo Prof Tag Anbar (Egypt) 11.40 am to 12.00 pm Vitiligo research and treatment: New horizon Prof D Parsad Session 8 Vitiligo : Surgical Management (1) Chairs: Dr Y Gauthier, Dr S Malakar 12.00 pm to 12.15 pm Practical issues for cellular grafting in vitiligo Dr S Mulekar (Saudi Arabia) 12.15 pm to 12.25 pm Stem Cells: New hope in vitiligo Dr Somesh Gupta 12.25 pm to 12.40 pm Differences in acral vitiligo skin where do we stand? Can these findings improve the treatment approach? Dr Samia Esmat (Egypt) 12.40 pm to 12.50 pm Tips to improve results in NCECS Dr T Salim 12.50 pm to 1.00 pm Ultra-skin thin grafts in vitiligo Dr Ravichandran Session 9: Melasma Chairs: 2.00 pm to 2.15 pm Therapeutic targets of melasma Prof H Y Kang (S Korea) 2.15 pm to 2.30 pm Treatment of melasma based on therapeutic targets Prof K C Park (S Korea) 2.30 pm to 2.45 pm Melasma Approach Dr K Godse

Session 10 : Vitiligo Support Chairs: 3.30 pm to 3.45 pm Vitiligo CloudBank: Electronic health record and Networked biobank for expedited R&D in Vitiligo Dr Y Valle (USA) 3.45 pm to 4.00 pm United 4 Vitiligo - Science and Society Interphase Dr Lipi Thukral 4.00 pm to 4.15 pm Quality of life of 213 Moroccan Dr B Laila (Morocco) with 4.15 pm to 4.30 pm Changing social paradigms about vitligo Dr M Tulpule 4.30 pm to 6.30 pm Trip to beating the retreat ceremony at Wagah Boarder 8.00 PM onwards Dinner Sunday, 30 th Nov 2014 Award papers 8.00 am to 9.30 am Session 11: Vitiligo Research: Future perspective Chairs: Dr MB Roscher, Dr R Begum 9.30 am to 9.50 am Regulating regulatory responses in vitiligo Dr C Le Poole (USA) 9.50 am to 10.05 am Role of Dermal stem cells: a new direction to vitiligo research Dr R Kumar 10.05am to 10.20am Animal model for Vitiligo: Buffalo gives hope! Dr Vijay Pal Singh

Session 12: Pigmentation Research Chairs: Prof K C Park, Prof V K Sharma 10.30 am to 10.45 am Clinical trial research for pigmentation Dr Mukta Sachdev 10.45 am to 11.00 am The paradigm of low dose medicine: low dose cytokine and growth factors in vitiligo Dr A Perra (France) 11.00 am to 11.15 am Kit receptor tyrosine kinase and skin color Dr Takahiro Kunisada (Japan) 11.15 am to 11.30 am Emerging role of STIM1, an intracellular calcium sensor, in pigmentation Dr R Motiani Session 13 Vitiligo : Surgical Management (2) Chairs: 11.30 am to 11.45 am Non-cultured epidermal cell suspension: New method Dr V Garg 11.45 am to 12.00 pm Evolution of surgical management of vitiligo: From tissue grafts to cellular grafts Dr A Budania 12.00 pm to 12.15 pm Evaluation of needling in vitiligo Dr A J Amar 12.15 pm to 12.30pm Surgical management of pediatric vitiligo Dr D Ghia Session 14: Gems and Pearls Chair: Dr Dimple Chopra, Dr S K Malhotra 12.30 pm to 12.45 pm Dermatosurgery: Pearls and gems MB Roscher (S Africa) 12.45 pm to 1.00 pm Unconventional treatments in melasma Dr N Khunger